Sonara Health Expands Remote Methadone Treatment With $2.5M Grant
22 Oct 2024 //
PR NEWSWIRE
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Video DOT Could Increase Access to Methadone Treatment and Reduce Risk
13 Oct 2022 //
BUSINESSWIRE
Berkshire Biomedical Awarded NIH Research Grant for Development of COPA System
25 Jul 2022 //
PRNEWSWIRE
Class 3 Recall: Martindale, Methadone 5mg Tablets / Physeptone 5mg Tablets
22 Nov 2021 //
GOV.UK
Relmada Therapeutics Announces Pricing of Public Offering of Common Stock
03 Dec 2019 //
PR NEWSWIRE
Notice of Amendment: List of Opioids (Part A): Buprenorphine and Methadone
01 Oct 2018 //
HEALTH CANADA
FDA Approves US WorldMeds` LUCEMYRA™ (lofexidine) After Priority Review
16 May 2018 //
PR NEWSWIRE
FDA targets anti-diarrhea pills that Penn doc calls `poor man`s methadone`
22 Mar 2018 //
BALTIMORESUN
How America’s prisons are fueling the opioid epidemic
14 Mar 2018 //
VOX
FDA to boost drug therapy for addicts
26 Feb 2018 //
NWA ONLINE
Relmada`s Acquires Global Rights to Develop and Market Dextromethadone Treatment
17 Jan 2018 //
PR NEWSWIRE
All Scientific Hands on Deck to End the Opioid Crisis
01 Jun 2017 //
DIRECTOS BLOG
How Ketamine could cure depression
30 Jan 2017 //
DRUG TARGET REVIEW
Relmada Announces FDA Acceptance of IND Phase 2a Clinical Trial for d-Methadone
26 Jan 2017 //
PR NEWSWIRE
Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects
05 May 2016 //
PR NEWS WIRE
Anti-HIV pill not cost effective among U.S. drug abusers
27 Apr 2016 //
REUTERS
Some Opioid Users On Methadone Have High Risk Of Relapse
15 Apr 2016 //
FORBES
Martindale removes povidone in oral methadone reformulation
21 Mar 2016 //
IN PHARMATECHNOLOGIST
ViiV Healthcare Announces PhII Study Results for First Two Drug
23 Feb 2016 //
PR NEWSWIRE
Use of Methadone to Treat Pain Ups Risk of Death, Vanderbilt University Study
22 Jan 2015 //
BIOSPACE
The Drug Suboxone Could Combat the Heroin Epidemic So Why is it So Hard to get
17 Jan 2015 //
THE WASHINGTON POST
Relmada Completes Multiple Ascending Dose Study of d-Methadone
04 Jan 2015 //
PR NEWS WIRE
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
30 Dec 2014 //
SUCAMPO PHARMACEUTICALS